ALR Technologies Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALRTF research report →
Price Chart
About the company
ALR Technologies Inc. is a data management company dedicated to creating and providing diabetes care solutions for both human and animal health sectors across the United States. Central to its offerings is the comprehensive Diabetes Management System.
- CEO
- Sidney S. Chan
- IPO
- 1998
- Employees
- 7
- HQ
- Singapore, VA, SG
Get TickerSpark's AI analysis on ALRTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $9.29M
- P/E
- -1.35
- PEG
- 0.04
- P/S
- 0.00
- P/B
- -0.66
- EV/EBITDA
- -1.96
- Div Yield
- 0.00%
- Gross Margin
- 66.22%
- Op Margin
- -39448.31%
- Net Margin
- -159306.37%
- ROE
- 51.64%
- ROIC
- 58.36%
Latest fiscal year · YoY change
- Revenue
- $7.47K+0.0%
- Gross Profit
- $4.95K+0.0%
- Op Income
- $-2,946,000
- Net Income
- $-11,897,000-101.1%
- EPS
- $-0.02-26.1%
- OCF Growth
- -82.6%
- FCF Growth
- -82.6%
- 52W High
- $0.02
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.02
- Beta
- 2.38
- RSI (14)
- 30
- Avg Volume
- 19.73K
No earnings-call transcripts are available for ALRTF yet.
- Free Float
- 39.7%
- Shares Outstanding
- 645.47M
- Float Shares
- 256.50M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Cheng Ronald | other | 0 |
| Nov 7, 22 | Cheng Ronald | other | 5,000,000 |
| Mar 18, 26 | Stafford Peter H | other | 0 |
| Mar 18, 26 | Stafford Peter H | other | 0 |
| Nov 7, 22 | Stafford Peter H | other | 10,000,000 |
| Nov 7, 22 | Szeto Benjamin | other | 10,000,000 |
| Mar 18, 26 | Kan Yuen Shan | other | 0 |
| Mar 18, 26 | Kan Yuen Shan | other | 0 |
| Nov 7, 22 | Kan Yuen Shan | other | 120,000,000 |
| Nov 7, 22 | Kan Yuen Shan | other | 115,500,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ALRTF coverage
Recent articles, reports, and earnings notes.
No research on ALRTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALRTF report →ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares
gurufocus.com · Jun 30
ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares
prnewswire.com · Jun 30
ALR TECHNOLOGIES HAS LAUNCHED THE GLUCURVE PET CGM IN CANADA
prnewswire.com · May 19
ALR TECHNOLOGIES TO RELAUNCH THE GLUCURVE PET CGM IN JANUARY 2026
prnewswire.com · Dec 8
ALR Technologies Completes Definitive Manufacturing Agreement for GluCurve Pet CGM
prnewswire.com · Jun 25
ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study
prnewswire.com · Sep 28
ALR Technologies Announces Canadian Launch Plans for the GluCurve Pet CGM
globenewswire.com · Aug 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.